APGE
Apogee Therapeutics·NASDAQ
--
--(--)
--
--(--)
APGE fundamentals
Apogee Therapeutics (APGE) released its earnings on Nov 10, 2025: revenue was 0 (YoY --), met estimates; EPS was -1.11 (YoY -29.07%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-1.11
-29.07%
Report date
Nov 10, 2025
EPS
Actual | -0.51 | -0.65 | -0.6 | -0.86 | -1.18 | -0.95 | -1.13 | -1.11 |
Forecast | -0.43 | -0.65 | -0.5983 | -0.879 | -1.1891 | -1.2159 | -1.0943 | -1.1248 |
Surprise | -18.60% | 0.00% | -0.28% | +2.16% | +0.77% | +21.87% | -3.26% | +1.32% |
Revenue
Actual | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What factors drove the changes in Apogee Therapeutics's revenue and profit?What is Apogee Therapeutics's gross profit margin?What is the market's earnings forecast for Apogee Therapeutics next quarter?What is the revenue and EPS growth rate for Apogee Therapeutics year over year?What is Apogee Therapeutics's latest dividend and current dividend yield?Did Apogee Therapeutics beat or miss consensus estimates last quarter?What were the key takeaways from Apogee Therapeutics's earnings call?What were the key takeaways from Apogee Therapeutics’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
